Uncertainty in measuring biodiversity change could hinder progress towards global targets for nature
More than ever before, there is a growing interest in dedicating resources to stop the loss of biodiversity, as recently exemplified by the Kunming-Montreal Global Biodiversity Framework (GBF) decided at COP15 in December 2022. The GBF focuses on understanding why biodiversity is declining and what actions are needed to reverse this trend. However, according to researchers at McGill University, implementing the plan is challenging because information about biodiversity changes is not evenly available everywhere, and is uncertain in many places.
With the available data, can the scientific community and policymakers truly know if they are making progress toward international biodiversity targets, even if their efforts were effective? The research says that without a better picture of how and why biodiversity is changing in most countries, it is difficult to evaluate the effect of national plans outlined in the GBF.
“Even if policies stopped the decline of animal populations, we show mathematically that it will be hard to detect improvements with high certainty, in many places for various types of species (48 of 62 countries and species groups),” explains Prof. Brian Leung from McGill’s Department of Biology and Bieler School of Environment and lead author of the study. “This is because detecting progress is limited by the current levels of uncertainty in the data (the records are either too sparse or too variable) describing animal population trends”.
To further this point, co-author Prof. Andrew Gonzalez compares this issue with monitoring recovery in heart health after an illness. “This would not be easy to do if a doctor had not kept good historical records about a person’s heart health and without good past records, it would be difficult to know if the heart is recovering because of the treatment it is receiving. Now, imagine trying to detect if heart health was improving on average across all Canadians (perhaps by following government recommendations on diet) if data on national heart health was not collected in the past or measured into the future.”
Prof. Gonzalez continues: “instead of heart health we assessed the health of animal populations - how fast they are declining or recovering – and whether we can conclude if populations are recovering worldwide. Tracking biodiversity targets and evaluating progress cannot be done well without filling the gaps in the information at hand and reducing the uncertainty that hinders our ability to evaluate if current trends are improving.”
Measuring efforts across the board
In light of these findings, how should the scientific community and policy makers evaluate their efforts to meet such ambitious goals like preserving 30% of land and water by 2030 and slowing the rate of human-caused species extinctions? The researchers make several suggestions, including proposing a risk framework that would establish unacceptable thresholds for biodiversity decline, which are easier to detect. Also, the authors suggest investment in a national and international biodiversity monitoring systems to improve trend estimates worldwide.
As Prof. Leung concludes: “Our results highlight that care must be taken to structure how we gather knowledge about biodiversity, so that we will be able to report whether we have succeeded in meeting our global targets given international investment in nature conservation or alternatively, whether we need to re-orient our actions.”
In summary, these recommendations put forward a more rigorous approach to interpreting biodiversity trends, incorporating risk considerations, boosting investment in monitoring, explicitly deciding thresholds for success, and the use of reference benchmarks to make informed conservation decisions. If implemented, many countries potentially could benefit, given the international reach of the GBF.
About the study
“Global monitoring for biodiversity: uncertainty, risk and power analyses to support trend change detection” by Brian Leung and Andrew Gonzalez was published in Sciences Advances.
About McGill University
Founded in Montreal, Quebec, in 1821, McGill University is Canada’s top ranked medical doctoral university. McGill is consistently ranked as one of the top universities, both nationally and internationally. It is a world-renowned institution of higher learning with research activities spanning three campuses, 11 faculties, 13 professional schools, 300 programs of study and over 39,000 students, including more than 10,400 graduate students. McGill attracts students from over 150 countries around the world, its 12,000 international students making up 30% of the student body. Over half of McGill students claim a first language other than English, including approximately 20% of our students who say French is their mother tongue.